2019/3 GaBI Journal Table of Contents

Contents

Editor’s Letter

Latest features in GaBI Journal, 2019, Issue 3

Commentary

Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective

Original Research

Pharmacy chain drives choice among manufacturers of generic drugs in the US Medicare population

Review Article

An ever-evolving landscape: an update on the rapidly changing regulation and reimbursement of biosimilars in Canada

Meeting Report

1st ASEAN overview workshop on GMP for biologicals/biosimilars 2018 – Report

Special Report

A progress report on the 3rd International Symposium on Scientific and Regulatory Advances in Biological and Non-Biological Complex Drugs: A to Z in Bioequivalence

Opinion

Why ‘similar’ can make a big difference

Source URL: https://gabi-journal.net/2019-3-gabi-journal-table-of-contents.html